Tens of thousands of teen girls suffer serious illnesses after HPV cervical cancer jab

    

The Medicines and Healthcare Products Regulatory Agency announced that 8,228 young girls had suffered debilitating side effects from the HPV injection.

However, the number is estimated to be only ten per cent of the true number of teens struck down with severe side effects after taking the vaccine.

The jab has been routinely administered to 12-year-old and 13-year-old girls in Britain since 2008. The injection blocks the sexually transmitted human papilloma virus which leads to most cervical cancer cases.

Otherwise healthy school-aged girls have reportedly suffered chest and abdominal pains, exhaustion, breathing difficulties, postural orthostatic tachycardia syndrome, which triggers an abnormally high heart rate, and fibromyalgia, which causes chronic pain throughout the body.

In more than a quarter of the cases, the effects have apparently been so severe that they were considered 'life-threatening' and required immediate medical treatment.

The concern over the injection is not new.

The Japanese health ministry has previously warned against the vaccination while European countries are continuing to re-evaluate its use.

Previously, links with infertility and early menopause have also been explored.

More than eight million people in the UK have been given the vaccination despite the ongoing links with grave conditions.

Jackie Fletcher, of the pressure group Jabs, said: "Previously fit and healthy young girls have developed seizures or viral fatigue, some have lost the ability to walk. And years on, some have still not recovered."

In a recent article in the journal Dr Martinez-Lavin wrote that although the HPV injection has been 'one of the most effective public health measures in the history of medicine', the level of side effects reported compared to other routine vaccinations is a growing concern.

In fact, the total number of illnesses associated with the HPV jab tops the number of side-effects reported in all other routine health programmes combined.

In light of their own report, the UK's MHRA has continued to claim that there were no 'major safety concerns' associated with the jab.

The watchdog insisted that the vaccine can save nearly half of the 1,000 women who die from the killer disease every year. It is the second most common cancer afflicting women under-35.

The agency maintains that the link with serious illnesses remains unproven while NHS asserts that the HPV vaccination programme has proven 'very effective'.